Adrenomedullin (AM) reflects cardiac dysfunction better than brain natriuretic peptide (BNP) in hemodialysis (HD) patients with cardiovascular disease

被引:0
|
作者
Yoshihara, F [1 ]
Horio, T [1 ]
Yoshii, M [1 ]
Nakamura, S [1 ]
Nakahama, H [1 ]
Inenaga, T [1 ]
Kangawa, K [1 ]
Kawano, Y [1 ]
机构
[1] Natl Cardiovasc Ctr, Suita, Osaka 565, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:173A / 173A
页数:1
相关论文
共 50 条
  • [1] CHANGES IN PLASMA BRAIN NATRIURETIC PEPTIDE (BNP) DURING HEMODIALYSIS (HD)
    TOTSUNE, K
    MOURI, T
    TAKAHASHI, K
    OHNEDA, M
    SONE, M
    MURAKAMI, O
    SAITO, T
    YOSHINAGA, K
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 321 - 321
  • [2] MOLECULAR-FORMS OF HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) IN PLASMA OF PATIENTS ON HEMODIALYSIS (HD)
    ISHIZAKA, Y
    YAMAMOTO, Y
    TANAKA, M
    KATO, F
    ISHIZAKA, Y
    YOKOTA, N
    KATO, J
    KITAMURA, K
    ETO, T
    KANGAWA, K
    MINAMINO, N
    MATSUO, H
    CLINICAL NEPHROLOGY, 1995, 43 (04) : 237 - 242
  • [3] Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease
    Henriksen, JH
    Gotze, JP
    Fuglsang, S
    Christensen, E
    Bendtsen, F
    Moller, S
    GUT, 2003, 52 (10) : 1511 - 1517
  • [4] Plasma concentration of brain natriuretic peptide (BNP) is useful for risk stratification in hemodialysis (HD) patients.
    Kawade, Y
    Ishii, J
    Watanabe, M
    Kasuga, H
    Yashima, A
    Yasuda, K
    Toriyama, T
    Kawahara, H
    Matsuo, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 589A - 589A
  • [5] Brain natriuretic peptide (Bnp): A marker for cardiovascular disease in pregnancy?
    Etoi, Garrison
    Hibbard, Judith
    Studec, Laura
    Deidra, Fontana
    Kilpatrick, Sarah
    Briller, Joan
    HYPERTENSION IN PREGNANCY, 2006, 25 : 228 - 228
  • [6] Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis. Relation to cardiovascular dysfunction and severity of disease
    Henriksen, JH
    Goetze, JP
    Fuglsang, S
    Christensen, E
    Bendtsen, F
    Moeller, S
    JOURNAL OF HEPATOLOGY, 2003, 38 : 29 - 29
  • [7] Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients
    Yoshihara, F
    Horio, T
    Nakamura, S
    Yoshii, M
    Ogata, C
    Nakahama, H
    Inenaga, T
    Kangawa, K
    Kawano, Y
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 1355 - 1363
  • [8] Brain Natriuretic Peptide (BNP): A New Risk Marker in Hemodialysis Patients?
    Jorge, Sofia
    Lopes, Jose Antonio
    Neves, Fernando
    da Costa, Antonio Gomes
    Prata, M. Martins
    SOUTHERN MEDICAL JOURNAL, 2008, 101 (11) : 1083 - 1083
  • [9] The role of plasma brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) in patients on chronic hemodialysis
    Satoh, S
    JOURNAL OF HYPERTENSION, 1998, 16 : S187 - S187
  • [10] HIGH LEVELS OF CIRCULATING BRAIN NATRIURETIC PEPTIDE (BNP) IN CIRRHOTIC PATIENTS ARE ASSOCIATED WITH ADVANCED LIVER DISEASE BUT NOT WITH CARDIAC DYSFUNCTION
    Casciato, Paola C.
    Villamil, Alejandro
    Marciano, Sebastian
    Bandi, Juan C.
    Gallardo, Patricia
    Giunta, Diego H.
    Galdame, Omar A.
    Gadano, Adrian
    HEPATOLOGY, 2010, 52 (04) : 915A - 915A